Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Medicine For All: The Case for a Public Option in the Pharmaceutical Industry

Author: Brown, D

Date: 2019

Language: English

Learn More: https://thenextsystem.org/medicineforall

You might also enjoy

FINALLY, THE PANDEMIC AGREEMENT!!! …… Many missed opportunities, but a beginning made

Read More »

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Read More »

Findings from T1International’s 2024 Out-of-Pocket Expenses and Rationing Survey

Read More »

Free trade agreement with Malaysia: Switzerland imperils the rights to food and health

Read More »

Making Access to Quality Healthcare a Top Priority for the EU

Read More »

Against the normalization of limited access to CAR-T cell therapies

Read More »